Perrigo reported Q3 2026 net sales below prior year figures, but its adjusted EPS significantly exceeded analyst expectations. The results reflect ongoing portfolio adjustments, including a divestiture, and headwinds from soft consumer demand, partially offset by market share gains in key categories.
Perrigo Company plc announced its third-quarter 2026 financial results, revealing a decline in net sales to $989 million from $1,043 million year-over-year. This sales miss is attributed to portfolio adjustments, notably the sale of its infant formula business, and broader market challenges like softer consumer demand and cautious retailer inventory. However, the company's adjusted EPS of $0.60 per share significantly surpassed the FactSet consensus estimate of $0.51, indicating better-than-expected profitability or cost management. This mixed performance suggests short-term headwinds on the top line but a stronger bottom line, which could be viewed positively by investors focusing on profitability and efficiency. The key opportunity for traders lies in assessing whether the EPS beat can offset the sales decline and if the 'share gains in key product categories' signal a stronger underlying business despite the macro pressures.